442 related articles for article (PubMed ID: 19684521)
21. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.
Zaoutis TE; Heydon K; Chu JH; Walsh TJ; Steinbach WJ
Pediatrics; 2006 Apr; 117(4):e711-6. PubMed ID: 16533892
[TBL] [Abstract][Full Text] [Related]
23. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
24. Retrospective assessment of secondary prophylaxis for invasive aspergillosis in neutropenic hematology patients and identification of risk factors for relapse of fungal disease.
Kikuchi M; Nakasone H; Mitani K; Gotoh M; Kobayashi A; Kurita N; Saito T; Sato K; Kanda Y;
Scand J Infect Dis; 2013 Jul; 45(7):531-6. PubMed ID: 23565772
[TBL] [Abstract][Full Text] [Related]
25. Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.
Kimura S; Oshima K; Sato K; Sato M; Terasako K; Nakasone H; Kikuchi M; Okuda S; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Nishida J; Kanda Y
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1355-61. PubMed ID: 20457267
[TBL] [Abstract][Full Text] [Related]
26. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
27. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
Cesaro S; Giacchino M; Locatelli F; Spiller M; Buldini B; Castellini C; Caselli D; Giraldi E; Tucci F; Tridello G; Rossi MR; Castagnola E
BMC Infect Dis; 2007 Apr; 7():28. PubMed ID: 17442100
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
31. Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
Babor F; Schuster F; Mackenzie C; Meisel R; Schaper J; Sabir H; Siepermann M; Wessalowski R; Janßen G; Borkhardt A; Laws HJ
Klin Padiatr; 2012 Apr; 224(3):160-5. PubMed ID: 22504775
[TBL] [Abstract][Full Text] [Related]
32. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
[TBL] [Abstract][Full Text] [Related]
33. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
[TBL] [Abstract][Full Text] [Related]
34. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
Cornillet A; Camus C; Nimubona S; Gandemer V; Tattevin P; Belleguic C; Chevrier S; Meunier C; Lebert C; Aupée M; Caulet-Maugendre S; Faucheux M; Lelong B; Leray E; Guiguen C; Gangneux JP
Clin Infect Dis; 2006 Sep; 43(5):577-84. PubMed ID: 16886149
[TBL] [Abstract][Full Text] [Related]
35. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.
Kontoyiannis DP; Chamilos G; Lewis RE; Giralt S; Cortes J; Raad II; Manning JT; Han X
Cancer; 2007 Sep; 110(6):1303-6. PubMed ID: 17614303
[TBL] [Abstract][Full Text] [Related]
36. [Invasive aspergillosis with extrapulmonary involvement: pathogenesis, clinical characteristics and prognosis].
López-Cortés LE; Garcia-Vidal C; Ayats J; Gudiol C; Bodro M; Sánchez-Ortega I; Peña C; Carratalá J
Rev Iberoam Micol; 2012; 29(3):139-43. PubMed ID: 22108606
[TBL] [Abstract][Full Text] [Related]
37. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
38. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Kontoyiannis DP; Ratanatharathorn V; Young JA; Raymond J; Laverdière M; Denning DW; Patterson TF; Facklam D; Kovanda L; Arnold L; Lau W; Buell D; Marr KA
Transpl Infect Dis; 2009 Feb; 11(1):89-93. PubMed ID: 18983417
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
